Clinical Trial Update: Acetylcysteine Against Acute Renal Insult During Cardiopulmonary Bypass. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating N-acetylcysteine to prevent acute kidney injury during cardiopulmonary bypass has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Kidney Injury

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Cardiovascular Disease, Renal Insufficiency, Acute | Phase 4 | Status: SUSPENDED